GHK-Cu, explained
A three-amino-acid peptide bound to copper, found naturally in human plasma. What cell, animal and small cosmetic studies have explored, and where the evidence stops.
GHK-Cu is a small peptide bound to copper that occurs naturally in the human body. It was first identified in blood plasma in the 1970s and has been studied since in cells, in animals and in small cosmetic studies of the skin. This guide explains what GHK-Cu is, what that research has explored, and where the evidence stops.
What GHK-Cu is
GHK takes its name from the one-letter codes for its three amino acids: glycine (G), histidine (H) and lysine (K). The peptide binds readily to copper, and the pairing is written GHK-Cu, after the chemical symbol for copper. It is also called copper tripeptide or, on cosmetic ingredient lists, copper tripeptide-1.
It was first described in 1973 by a researcher who isolated it from human plasma. It has since been found in saliva and urine as well, and published measurements suggest that the amount in plasma falls with age.
What researchers have studied
In cell-culture experiments, GHK-Cu has been examined for its effect on fibroblasts, the cells that produce collagen and other structural components of skin, and on the activity of genes involved in building and breaking down tissue. In animals, it has been studied in models of wound repair. Copper is itself required by enzymes involved in forming connective tissue, and one long-standing idea is that the peptide acts as a carrier that moves copper into cells.
In people, the published work consists mainly of small studies of cosmetic skincare products containing GHK-Cu, which assessed the appearance of the skin. Most were short and involved few participants, and they measured cosmetic appearance, not a medical outcome.
These are observations about how the peptide behaves in experimental systems and in cosmetic use. They are hypotheses about mechanism, not demonstrations of a medical benefit in people.
Where the evidence stops
Human research on GHK-Cu as a medicine is limited. There are no large, controlled clinical trials establishing that it is safe or effective for any condition, and its long-term safety as a prescribed medication has not been characterized. A change in how cells behave in a dish, or in how skin looks in a small cosmetic study, is not evidence of a medical benefit for a person.
A cosmetic ingredient and a prescription are different things
GHK-Cu is widely sold in over-the-counter skincare. Cosmetic products do not go through FDA approval before they are sold, and a cosmetic may not be marketed as a medicine. Seeing the ingredient on a store shelf says nothing about what it does as a drug.
A compounded prescription is a different product: it is prepared by a pharmacy for one patient, on a provider's order, after an evaluation. Neither a cosmetic nor a compounded preparation is an FDA-approved medication.
What a prescribed protocol looks like
The form, the amount, the schedule and the duration of any protocol are decisions made by the prescribing provider for the individual patient. Nothing in this article should be read as a dosing recommendation. If a source online sells GHK-Cu as a medication without a licensed provider and a real evaluation involved, treat that as a warning sign, not a shortcut.
FDA status and compounding: what to know
The regulatory picture here deserves precision. GHK-Cu is not an FDA-approved medication: no product containing it has been approved by the FDA as a drug for any use. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety or efficacy.
GHK-Cu is not yet available through Peptivik. If and when it is offered, it will be by prescription only, after an evaluation by a licensed provider, and prepared for individual patients by state-licensed US compounding pharmacies — a different regulatory lane than FDA premarket review, and one you should expect any honest platform to disclose plainly.
If you compete in a tested sport
Anti-doping rules restrict a number of peptides, including substances that have no regulatory approval. If you are subject to drug testing, check your sport's current prohibited list before considering GHK-Cu.
Questions worth asking a provider
- What the human evidence does and does not show for the reason you are considering it.
- Whether there is an established, approved treatment for your situation that should be considered first.
- How a prescribed preparation differs from the cosmetic products that list the same ingredient.
- What is known, and what is not known, about side effects and long-term safety.
- What they would want to evaluate first, and what would lead them to advise against it.
The bottom line
GHK-Cu is a three-amino-acid peptide bound to copper that occurs naturally in the body, studied in cells, in animals and in small cosmetic studies of the skin. Evidence for it as a medicine is limited, and it is not FDA-approved for any use. Whether it is appropriate for you is a decision that belongs with a licensed provider who can weigh that limited evidence against your health history.
This content is educational and not a substitute for advice from your provider.